Interestingly, in the GBM subgroup described by Noushmehr et al., tumours presenting G-CIMP prevailed among younger patients (median age being 36 versus 56 years, p < 0.001) and correlated with the presence of the IDH1 mutation. The gene discussed is IDH1; the disease is glioblastoma.